Adverse general reactions to high doses of methylglucamine-based contrast media.
D000272:Adipates; D000328:Adult; D000367:Age Factors; D000469:Alkaline Phosphatase / Q000097:blood; D000606:Amino Sugars / Q000009:adverse effects*; D002118:Calcium / Q000097:blood; D002744:Chlorpheniramine / Q000627:therapeutic use; D003287:Contrast Media / Q000009:adverse effects*; D003973:Diatrizoate / Q000009:adverse effects; D003975:Diazepam / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D006961:Hyperparathyroidism / Q000000981:diagnostic imaging; D007022:Hypotension / Q000139:chemically induced; D007483:Iothalamic Acid / Q000009:adverse effects; D008875:Middle Aged; D009127:Muscle Rigidity / Q000139:chemically induced / Q000188:drug therapy; D010710:Phosphates / Q000097:blood; D011859:Radiography; D013012:Sorbitol / Q000009:adverse effects*; D013997:Time Factors; D014508:Urea / Q000097:blood; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy
D000272:Adipates; D000606:Amino Sugars; D003287:Contrast Media; D010710:Phosphates; D003973:Diatrizoate; D007483:Iothalamic Acid; D002744:Chlorpheniramine; D013012:Sorbitol; D014508:Urea; D000469:Alkaline Phosphatase; D003975:Diazepam; D002118:Calcium